Colorectal Cancer Clinical Trials in Pennsylvania

Showing 261-280 of 282 trials

Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

NCT00017082

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of oxaliplatin in treating patients who have recurrent metastatic colorectal cancer.

Colorectal Cancer

Prologue Research InternationalStarted Apr 2001

Washington D.C., District of Columbia, United States • Boca Raton, Florida, United States • Louisville, Kentucky, United States +7 more locations

COMPLETEDNA36 miles

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

NCT00005809

RATIONALE: New diagnostic procedures such as computed tomographic colonography may provide a less invasive method of identifying patients who have colorectal neoplasia. PURPOSE: Diagnostic study to compare the effectiveness of computerized tomographic colonography with that of standard diagnostic procedures in detecting colorectal neoplasia.

Colorectal Cancer

American College of Radiology Imaging NetworkStarted Jul 2000

Birmingham, Alabama, United States • Los Angeles, California, United States • San Francisco, California, United States +8 more locations

Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

Colorectal Cancer Trials in Other Cities

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer

Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer

Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Comparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon Cancer

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Study of XL281 in Adults With Solid Tumors

Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening.

GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer

Other Conditions in Pennsylvania